176 related articles for article (PubMed ID: 6339921)
1. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
Rodeheffer RJ; Rommer JA; Wigley F; Smith CR
N Engl J Med; 1983 Apr; 308(15):880-3. PubMed ID: 6339921
[No Abstract] [Full Text] [Related]
2. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
[TBL] [Abstract][Full Text] [Related]
3. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
Baadsgaard O; Schmidt JF; Ironmann L
Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
[No Abstract] [Full Text] [Related]
4. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
Pisenti L; Hart LL
Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
[No Abstract] [Full Text] [Related]
5. Nifedipine for Raynaud's phenomenon.
Lancet; 1983 Jan; 1(8316):130. PubMed ID: 6129447
[No Abstract] [Full Text] [Related]
6. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
Smith CD; McKendry RJ
Lancet; 1982 Dec; 2(8311):1299-301. PubMed ID: 6128596
[TBL] [Abstract][Full Text] [Related]
8. [Use of nifedipine in patients with Raynaud's phenomenon].
Rozwodowska M; Polaszewska-Muszyńska M; Ukleja-Adamowicz M; Rewakowicz M; Guzowska M; Marunowska A; Jundziłł W; Wodyńska T; Ruchalski M; Strzelecki A
Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
[No Abstract] [Full Text] [Related]
9. [Calcium antagonists for the treatment of Raynaud's phenomenon].
Müller-Bühl U; Diehm C; Scheuermann W; Mörl H
Dtsch Med Wochenschr; 1983 Nov; 108(47):1795-7. PubMed ID: 6357692
[TBL] [Abstract][Full Text] [Related]
10. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
Rhedda A; McCans J; Willan AR; Ford PM
J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
[TBL] [Abstract][Full Text] [Related]
11. Slow release nifedipine in the treatment of Raynaud's phenomenon.
Costantini A; Martelli E; Bavera P; Agus GB
Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
[TBL] [Abstract][Full Text] [Related]
12. [Nicardipine in the treatment of Raynaud's phenomenon].
Kahan A; Amor B; Menkès CJ
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
[TBL] [Abstract][Full Text] [Related]
13. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
[No Abstract] [Full Text] [Related]
15. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
Sarkozi J; Bookman AA; Mahon W; Ramsay C; Detsky AS; Keystone EC
J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
17. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
Corbin DO; Wood DA; Macintyre CC; Housley E
Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
[TBL] [Abstract][Full Text] [Related]
18. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
Challenor VF; Waller DG; Hayward RA; Griffin MJ; Roath OS
Angiology; 1989 Feb; 40(2):122-8. PubMed ID: 2644877
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Raynaud's syndrome with calcium entry blockers].
Shcherbakov AB; Guseva NG; Mach ES
Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
[TBL] [Abstract][Full Text] [Related]
20. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
Lukác J; Rovenský J; Tauchmannová H; Zitnan D
Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
